Recombinant Human GFY Protein: Handling & Usage Protocol

Recombinant Human GFY Protein is a research-grade recombinant protein reagent requiring careful reconstitution, precise storage, and appropriate handling to ensure maximal biological activity and experimental reproducibility.

Product Name

Recombinant Human GFY Protein

SKU

rp367934

Species

Human (Homo sapiens)

Protein Type

Recombinant protein

Recommended Storage

-20°C or -80°C; avoid repeated freeze-thaw cycles

Application

In vitro research applications including functional assays and protein interaction studies

Materials and Equipment Required

Before beginning, ensure the following materials and equipment are available in the laboratory:

• Recombinant Human GFY Protein (Aladdin SKU: rp367934)
• Sterile, nuclease-free water or an appropriate reconstitution buffer (e.g., PBS, pH 7.4)
• Calibrated micropipettes and sterile low-binding microcentrifuge tubes
• Vortex mixer and benchtop microcentrifuge
• Ice bucket or cooling block
• Appropriate PPE: gloves, lab coat, and eye protection
• -20°C or -80°C freezer for long-term storage

Verify that all consumables are sterile and free from protease contamination prior to use. Prepare all reagents at room temperature unless otherwise indicated.

Reconstitution Procedure

Follow the steps below to reconstitute Recombinant Human GFY Protein:

1. Equilibration: Allow the lyophilized protein vial to equilibrate to room temperature for 10–15 minutes before opening. This minimizes moisture condensation inside the vial.
2. Centrifugation: Briefly centrifuge the sealed vial (1,000–2,000 × g for 30 seconds) to collect all lyophilized material at the bottom of the vial.
3. Addition of Reconstitution Buffer: Add the recommended volume of sterile reconstitution buffer (refer to the product datasheet for the specific volume) slowly along the inner wall of the vial. Do not add buffer directly onto the lyophilized cake to prevent foaming.
4. Gentle Mixing: Gently swirl or rotate the vial to dissolve the protein. Avoid vigorous vortexing, which can denature the protein. If needed, allow the vial to sit at room temperature for 5 minutes to facilitate dissolution.
5. Inspection: Visually inspect the solution to confirm complete dissolution. The solution should be clear and free of visible particulates. If particulates remain, gently centrifuge before use.
6. Aliquoting: Divide the reconstituted protein into single-use aliquots using sterile low-binding tubes to avoid repeated freeze-thaw cycles that can reduce activity.

Note: Consult the product datasheet (absea#PP-1901) for protein-specific reconstitution buffer recommendations and final concentration details.

Storage and Stability Guidelines

Proper storage is critical to maintaining the biological activity and integrity of Recombinant Human GFY Protein:

• Short-term storage (up to 1 week): Store reconstituted protein at 4°C. Add a carrier protein such as 0.1% BSA to stabilize the protein if required by the intended application.
• Long-term storage: Store aliquots at -20°C or preferably -80°C for extended periods. Lyophilized protein may be stored at -20°C for up to 12 months from the date of receipt when kept desiccated.
• Freeze-thaw cycles: Limit freeze-thaw cycles to a minimum (ideally no more than 2–3 cycles). Each freeze-thaw event can significantly degrade protein activity and structural integrity.
• Avoid: Do not store protein in frost-free freezers, which undergo temperature cycling. Avoid prolonged exposure to room temperature.
• Carrier protein: For dilute working solutions, the addition of a stabilizing carrier protein (e.g., 0.1% BSA in PBS) is recommended to prevent adsorption to tube surfaces and activity loss.

Always refer to the product-specific datasheet (absea#PP-1901) for definitive storage conditions and shelf-life data.

Experimental Application Guidelines

Recombinant Human GFY Protein is intended for in vitro research applications. The following general guidelines apply when incorporating this protein into experimental workflows:

• Working concentration: Optimize the working concentration empirically for each specific assay. Titration experiments are recommended to determine the minimum effective concentration for your application.
• Buffer compatibility: Ensure that the assay buffer is compatible with the protein storage buffer. Significant buffer mismatches can affect protein conformation and activity. Dialysis or buffer exchange may be required.
• Protein quantification: Prior to use, confirm protein concentration using a validated method such as BCA assay, Bradford assay, or absorbance at 280 nm (A280), taking into account the protein's extinction coefficient.
• Endotoxin considerations: For cell-based assays, verify that endotoxin levels are within acceptable limits. Elevated endotoxin can confound biological results, particularly in immune cell studies.
• Controls: Always include appropriate positive and negative controls in every experiment to validate assay performance and protein activity.
• Equipment calibration: Ensure all analytical instruments (plate readers, spectrophotometers) are calibrated before use.

Specific application protocols and recommended assay conditions may be found in the product datasheet (absea#PP-1901). Contact Aladdin Scientific technical support for application-specific guidance.

Troubleshooting

If unexpected results are observed, consider the following troubleshooting steps:

Issue	Possible Cause	Recommended Action
Poor or incomplete dissolution	Insufficient buffer volume or incorrect buffer pH	Add additional buffer in small increments; verify buffer pH and composition against datasheet recommendations
Reduced protein activity	Repeated freeze-thaw cycles or improper storage temperature	Use freshly prepared aliquots; review storage conditions; avoid frost-free freezers
Visible aggregation or precipitation	Protein concentration too high or incompatible buffer	Centrifuge to remove aggregates; dilute protein; consider buffer exchange
High background in assay	Endotoxin contamination or non-specific binding	Test endotoxin levels; use low-binding plates and tubes; optimize blocking conditions
Inconsistent results between experiments	Variability in working concentration or freeze-thaw history	Prepare fresh aliquots; standardize protein quantification; use consistent lot numbers where possible

For technical assistance, contact Aladdin Scientific customer support and reference product SKU rp367934 and datasheet absea#PP-1901.

Frequently asked questions

How should Recombinant Human GFY Protein be reconstituted?

Allow the lyophilized vial to reach room temperature, briefly centrifuge to collect the powder, then add the recommended volume of sterile reconstitution buffer slowly along the inner vial wall. Gently swirl to dissolve and avoid vigorous vortexing to prevent denaturation. Refer to the product datasheet (absea#PP-1901) for the specific buffer and volume.

What are the recommended storage conditions for Recombinant Human GFY Protein?

Lyophilized protein should be stored at -20°C in desiccated conditions for up to 12 months from receipt. After reconstitution, aliquot and store at -80°C for long-term use or at 4°C for up to one week. Minimize freeze-thaw cycles to preserve protein activity.

How many freeze-thaw cycles can Recombinant Human GFY Protein tolerate?

It is generally recommended to limit freeze-thaw cycles to no more than 2–3 times. Repeated freeze-thaw cycles can cause protein aggregation, denaturation, and significant loss of biological activity. Single-use aliquots are strongly recommended to avoid this issue.

What applications is Recombinant Human GFY Protein suitable for?

Recombinant Human GFY Protein is intended for in vitro research applications. Typical uses include functional activity assays, protein–protein interaction studies, and use as a standard or control in relevant immunoassays. Please consult the product datasheet (absea#PP-1901) for validated applications and recommended conditions.

What should I do if the protein does not dissolve completely after reconstitution?

If incomplete dissolution is observed, allow the vial to rest at room temperature for an additional 5–10 minutes and gently swirl again. Verify that the correct buffer and volume are being used as specified in the datasheet. If particulates persist, centrifuge the solution briefly at low speed and use the supernatant. Contact Aladdin Scientific technical support if the problem continues.

References

1. Aladdin Scientific. Recombinant Human GFY Protein, SKU rp367934. Product Datasheet absea#PP-1901.
2. Wingfield PT. Overview of the purification of recombinant proteins. Current Protocols in Protein Science. 2015;80:6.1.1-6.1.35. doi:10.1002/0471140864.ps0601s80
3. Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Frontiers in Microbiology. 2014;5:172. doi:10.3389/fmicb.2014.00172

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.